BPC-157 Thymosin Beta-4 Capsules

Price range: $148.73 through $267.71

BPC-157 Thymosin Beta-4 Capsules combine 500mcg BPC-157 Arginate and 500mcg Thymosin Beta-4 per capsule across 60 capsules per unit, manufactured to ≥98% purity for advanced preclinical research applications. This dual-peptide formulation is designed for laboratory use in studies related to tissue repair signaling, neuroinflammation, and cellular regeneration pathways. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: bpc-157-thymosin-beta-4-capsules Category:
Description

BPC-157 Thymosin Beta-4 Capsules are a dual-peptide research formulation combining BPC-157 Arginate and Thymosin Beta-4, each dosed at 500mcg per capsule, manufactured to ≥98% purity for use in laboratory and preclinical research settings. These capsules provide a convenient, consistent delivery format for researchers investigating peptide-based mechanisms in controlled environments. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

Direct Anti Peptide is proud to offer BPC-157 Thymosin Beta-4 Capsules as part of our premium research peptide catalog. This dual-peptide compound brings together two of the most actively studied peptides in regenerative and neurological research. BPC-157 Arginate is a stabilized derivative of a peptide fragment originally identified in gastric juice, while Thymosin Beta-4 is a naturally occurring, highly conserved protein fragment involved in actin sequestration and cellular signaling. Together, they represent a compelling area of scientific inquiry into tissue repair, inflammation modulation, and neuroprotection. Researchers seeking to buy BPC-157 Thymosin Beta-4 Capsules online will find our offering competitively priced with verified analytical credentials.

Peptide Structure & Amino Acid Sequence

BPC-157 Arginate is a 15-amino acid synthetic peptide derived from the body protection compound sequence found in human gastric juice. Its arginate salt form offers enhanced stability. Thymosin Beta-4, also referred to as TB-4 or TB-500 fragment, is a 43-amino acid polypeptide with a well-characterized role in G-actin sequestration and upregulation of cell migration factors. The combination of these two structurally distinct peptides in a single capsule format makes this product a unique and efficient tool for multi-pathway research protocols.

Chemical & Physical Characteristics

  • Formulation: Dual-peptide encapsulated compound
  • BPC-157 Arginate per capsule: 500mcg
  • Thymosin Beta-4 per capsule: 500mcg
  • Purity: ≥98% (verified by HPLC and MS)
  • Appearance: White to off-white lyophilized powder, encapsulated
  • Capsule count: 60 capsules per unit
  • Solubility: Water-soluble components; encapsulated for dry-state stability

Purity & Analytical Verification (HPLC & MS)

Every batch of BPC-157 Thymosin Beta-4 Capsules produced for Direct Anti Peptide undergoes rigorous analytical testing. High-Performance Liquid Chromatography (HPLC) is used to confirm peptide purity at or above the ≥98% threshold, while Mass Spectrometry (MS) validates the molecular identity and correct amino acid composition of both peptide components. These dual verification methods ensure that researchers receive a product of consistent, publication-grade quality with every order.

Quality Control & Lyophilization Integrity

Prior to encapsulation, both peptide components are lyophilized under controlled freeze-drying conditions to remove residual moisture and preserve structural integrity. The lyophilization process minimizes degradation risk and extends the shelf life of the active compounds. Capsules are then filled under quality-controlled conditions to ensure accurate dosing consistency across all 60 units per container. Batch-level quality control documentation is maintained to support traceability and research reproducibility.

Safety, Handling & Laboratory Precautions

This product is strictly intended for in vitro and preclinical laboratory research. Researchers should handle all peptide compounds using standard laboratory safety protocols, including the use of appropriate personal protective equipment (PPE) such as gloves, eye protection, and lab coats. Capsules should not be opened, dissolved, or reformulated outside of a controlled research environment. Keep out of reach of children. This compound is not approved for any form of human or animal administration.

Reconstitution, Packaging & Storage

BPC-157 Thymosin Beta-4 Capsules are supplied in sealed, light-resistant containers to protect peptide integrity from UV exposure and humidity. For optimal stability, store in a cool, dry environment away from direct light. Recommended storage temperature is 2–8°C for short-term use, or −20°C for long-term archival. Do not freeze-thaw repeatedly. These capsules are intended for dry-state research use and should be handled in accordance with institutional laboratory guidelines.

Intended Research Use & Market Positioning

Scientific literature increasingly highlights the roles of BPC-157 and Thymosin Beta-4 in areas such as angiogenesis, neuroinflammation, and cellular repair signaling. Researchers are actively investigating these peptides in the context of traumatic brain injury models, neurodegenerative disease pathways including ALS and Alzheimer’s-related mechanisms, gastrointestinal repair, and musculoskeletal recovery. The capsule format supports standardized, reproducible dosing across experimental cohorts, making this product particularly suited for longitudinal preclinical studies.

Ordering, Availability & Fulfillment

Direct Anti Peptide offers BPC-157 Thymosin Beta-4 Capsules for sale with fast order processing, secure checkout, and reliable domestic and international fulfillment. Whether you are looking to order now for a single research cycle or stock your laboratory with a bulk supply at the best price, our team ensures prompt dispatch and discreet packaging. All orders are processed with full compliance documentation available upon request.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. BPC-157 Thymosin Beta-4 Capsules are sold exclusively as laboratory research reagents. Direct Anti Peptide makes no therapeutic claims regarding this product. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international regulations governing the acquisition, possession, and use of research peptides. This product has not been evaluated or approved by any regulatory authority for use in humans or animals.

Additional information
Size:

60 Capsules

,

60 Capsules Twin Pack

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “BPC-157 Thymosin Beta-4 Capsules”

Your email address will not be published. Required fields are marked *

Shipping & Delivery